UK Campaigner Pushes for £8K MND Drug Access on NHS
A father who lost his dad to Motor Neurone Disease is fighting to make a treatment that slows the condition available to NHS patients. The drug Tofersen costs just £8,000 per patient and has shown remarkable results for people with a specific gene variation.